Cargando…
Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391285/ https://www.ncbi.nlm.nih.gov/pubmed/31616064 http://dx.doi.org/10.1038/s41409-019-0717-8 |
| _version_ | 1783564604774809600 |
|---|---|
| author | Mascarenhas, Kristen Teh, Jennifer Berano Peng, Kelly Kim, Heeyoung Sy, Andrew Forman, Stephen J. Wong, F. Lennie Nakamura, Ryotaro Dadwal, Sanjeet S. Armenian, Saro H. |
| author_facet | Mascarenhas, Kristen Teh, Jennifer Berano Peng, Kelly Kim, Heeyoung Sy, Andrew Forman, Stephen J. Wong, F. Lennie Nakamura, Ryotaro Dadwal, Sanjeet S. Armenian, Saro H. |
| author_sort | Mascarenhas, Kristen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7391285 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73912852020-08-11 Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation Mascarenhas, Kristen Teh, Jennifer Berano Peng, Kelly Kim, Heeyoung Sy, Andrew Forman, Stephen J. Wong, F. Lennie Nakamura, Ryotaro Dadwal, Sanjeet S. Armenian, Saro H. Bone Marrow Transplant Correspondence Nature Publishing Group UK 2019-10-15 2020 /pmc/articles/PMC7391285/ /pubmed/31616064 http://dx.doi.org/10.1038/s41409-019-0717-8 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Mascarenhas, Kristen Teh, Jennifer Berano Peng, Kelly Kim, Heeyoung Sy, Andrew Forman, Stephen J. Wong, F. Lennie Nakamura, Ryotaro Dadwal, Sanjeet S. Armenian, Saro H. Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation |
| title | Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation |
| title_full | Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation |
| title_fullStr | Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation |
| title_full_unstemmed | Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation |
| title_short | Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation |
| title_sort | efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391285/ https://www.ncbi.nlm.nih.gov/pubmed/31616064 http://dx.doi.org/10.1038/s41409-019-0717-8 |
| work_keys_str_mv | AT mascarenhaskristen efficacyoflowdosezosterprophylaxisinpatientsundergoingallogeneichematopoieticcelltransplantation AT tehjenniferberano efficacyoflowdosezosterprophylaxisinpatientsundergoingallogeneichematopoieticcelltransplantation AT pengkelly efficacyoflowdosezosterprophylaxisinpatientsundergoingallogeneichematopoieticcelltransplantation AT kimheeyoung efficacyoflowdosezosterprophylaxisinpatientsundergoingallogeneichematopoieticcelltransplantation AT syandrew efficacyoflowdosezosterprophylaxisinpatientsundergoingallogeneichematopoieticcelltransplantation AT formanstephenj efficacyoflowdosezosterprophylaxisinpatientsundergoingallogeneichematopoieticcelltransplantation AT wongflennie efficacyoflowdosezosterprophylaxisinpatientsundergoingallogeneichematopoieticcelltransplantation AT nakamuraryotaro efficacyoflowdosezosterprophylaxisinpatientsundergoingallogeneichematopoieticcelltransplantation AT dadwalsanjeets efficacyoflowdosezosterprophylaxisinpatientsundergoingallogeneichematopoieticcelltransplantation AT armeniansaroh efficacyoflowdosezosterprophylaxisinpatientsundergoingallogeneichematopoieticcelltransplantation |